HuagongsheHuagongshe Chemistry Print Report · For research reference only
Dimedone → 4-[(E)-2-(5-Bromopyridin-2-yl)vinyl]-7,7-dimethyl-5-oxo-4,5,6,7,8,9-hexahydro-1H-pyrazolo[3,4-b]quinoline 3-cyclopropylmethylcarboxamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Dimedone | HCID 31358 | — |
| Reactant | 3-(5-Bromopyridin-2-yl)prop-2-enal | HCID 86676730 | — |
| Reactant | 5-amino-1H-pyrazole 3-cyclopropyl methylcarboxamide | HCID 131731709 | — |
| Product | 4-[(E)-2-(5-Bromopyridin-2-yl)vinyl]-7,7-dimethyl-5-oxo-4,5,6,7,8,9-hexahydro-1H-pyrazolo[3,4-b]quinoline 3-cyclopropylmethylcarboxamide | HCID 137195800 | — |
Reaction Steps
The title compound is prepared analogously to procedure A from 150 mg of (E)-3-(5-bromopyridin-2-yl)propenal, 100 mg of dimedone and 127 mg of 5-amino-1H-pyrazole-3-cyclopropyl methylcarboxamide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08791133B2 |
| Source dataset | uspto-grants-2014_07 |
| ORD ID | ord-61630322f84d4471b97bc6945497a243 |
| Source note | uspto-grants-2014_07 |